Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
418805-02-4
PubMed Central PMCID: PMC5083757
complete degradation of DNMT1 protein was achieved within 24 h without significantly affecting its mRNA level
Epub 2019 May 29
PAI-039 - CAS# 393105-53-8 size:2mg solid 418805-02-4PAI 039, CAS No. 393105 53 8, is a novel plasminogen activator inhibitor 1 (PAI 1) inhibitor. The pharmacokinetic profile of PAI 039 indicated an oral bioavailability of 43 + 15. 3% and a plasma half life of 6. 2 + 1. 3 h. PAI 039 is an orally active prothrombolytic drug that inhibits PAI 1 and accelerates fibrinolysis while maintaining normal coagulation in a model of coronary occlusion . PAI 039 exerts antithrombotic efficacy in rat models of
US$ 86.00
US$ 131.00
US$ 24.00
US$ 1099.50
US$ 34.00
US$ 105.00
US$ 150.00
US$ 18.00
US$ 40.00
US$ 20.00